Michael Polydefkis, MD - TTRemendous Advances in Transthyretin Amyloidosis Treatment: What Neurologists Need to Know

PeerView Clinical Pharmacology CME/CNE/CPE Video

Conteúdo fornecido por PeerView, 24 West 40th Street, Suite 950, New York, NY 10018, PVI, and PeerView Institute for Medical Education. Todo o conteúdo do podcast, incluindo episódios, gráficos e descrições de podcast, é carregado e fornecido diretamente por PeerView, 24 West 40th Street, Suite 950, New York, NY 10018, PVI, and PeerView Institute for Medical Education ou por seu parceiro de plataforma de podcast. Se você acredita que alguém está usando seu trabalho protegido por direitos autorais sem sua permissão, siga o processo descrito aqui https://pt.player.fm/legal.

1M ago 58:01

M4V•Home de episódios

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.

For the full presentation, downloadable Practice Aids, slides, and complete CME information, and to apply for credit, please visit us at PeerView.com/ZHC865. CME credit will be available until July 15, 2025.

TTRemendous Advances in Transthyretin Amyloidosis Treatment: What Neurologists Need to Know

In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Support
This activity is supported by an independent educational grant from AstraZeneca LP.

Disclosure information is available at the beginning of the video presentation.

620 episódios

#Science #Medical Education #Continuing Medical Education #Cme Credits #Insession #Inreview #Cne #CPE #Clinical Pharmacology #PVI #PeerView Institute for Medical Education #Video #Fitness #Podcasting Education #Medicine #CME #PeerView